- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05652010
Clinical Investigation of an Improved Two-piece Stoma Product for People Living With a Stoma (CP343)
A Randomized, Controlled Clinical Investigation of an Improved Two-piece Stoma Product for People Living With a Stoma
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Open-label, randomized, controlled, comparative, cross-over study with 2 test sequences comparing a new 2p coupling system with SenSura Mio Click. Each test period is 3 weeks (± 2 days), total study period is 6 weeks (± 4 days). It will be a 1:1 randomization into the two possible treatment sequences.
The investigation will require 50 randomized subjects (exp. 20% drop-out), leading to at least 40 completed subjects. The sample size calculation is based on at least 6 bag changes during each test period (≥2 chang-es per week).
All visits will be performed as remote virtual calls. At the visits, the investigator (or designee) will give in-structions for the coming period and check that the trial is running as planned. At every bag change the sub-ject will be asked to complete a questionnaire.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Carri Browne
- Phone Number: 16123235772
- Email: dkcarr@coloplast.com
Study Locations
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28277
- American Health Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Has given written consent to participate by signing the Informed Consent Signature Form
- Be at least 18 years of age and have full legal capacity
- Is able to handle (apply, remove, cut, etc.) the product and do the assessments themselves
Has an ileostomy or colostomy with consistent liquid fecal output (for colostomy: 6-7 Bristol stool scale*)
*See appendix 1
- Currently use SenSura Mio Click 2p Click flat or concave with 50 mm coupling size
- Have had their ostomy for at least 90 days
- Be willing to change the bag at least twice per week
- Is willing and suitable (determined by the Principal Investigator or designee) to use flat or concave 2p open product during the investigation
- Is willing to use 2p maxi open bags during the investigation
Exclusion Criteria:
Is currently receiving or have within the past 60 days received radio-and/or chemotherapy
- low doses radio- and/or chemotherapy (assessed by Principal Investigator) is allowed for indications other than cancer.
Is currently receiving or have within the past 30 days received topical steroid treatment in the peristomal skin area, e.g., lotion or spray
- Low dose systemic steroid treatment (e.g., inhalation) assessed by the investigator are allowed.
- Other systemic steroid treatment (e.g., injection or tablet) are not allowed.
- Is pregnant and/or breast-feeding
- Have a loop ileostomy
- Is currently using convex baseplate
- Has known hypersensitivity towards any of the products used in the investigation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: New Coupling
|
|
Active Comparator: Comparator Device
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Coupling Leakage
Time Frame: 3 weeks
|
Leakage through coupling registered at each bag change (yes/no).
|
3 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CP343
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stoma Site Leakage
-
NorthShore University HealthSystemTerminatedStoma Site LeakageUnited States
-
Coloplast A/SCompletedStoma Site LeakageDenmark
-
Coloplast A/SRecruitingQuality of Life | Nurse's Role | Colostomy Stoma | Stoma Ileostomy | Stoma Site LeakageDenmark
-
Ataturk UniversityNot yet recruitingLife Style, Healthy | Intestinal Stoma Site Hemorrhage | Intestinal Stoma LeakageTurkey
-
Campus Bio-Medico UniversityCompletedIleostomy; Complications | Ileostomy - Stoma | Leakage, Anastomotic
-
St. James's Hospital, IrelandNot yet recruitingIleostomy - Stoma | Colostomy Stoma | Stoma Site InfectionIreland
-
Cukurova UniversityCompleted
-
Shanghai 10th People's HospitalRecruitingRectum Cancer | Faecal Incontinence | Stoma Colostomy | Leakage, AnastomoticChina
-
Chang Gung Memorial HospitalConvaTect, TaiwanUnknownStoma Ileostomy | Stoma ColostomyTaiwan
-
Coloplast A/SCompleted
Clinical Trials on Iris - new coupling
-
Intelligent Medical Implants GmbHUnknownRetinitis Pigmentosa | Choroideremia | Cone-Rod Dystrophy
-
University of Missouri-ColumbiaCompleted
-
VA Office of Research and DevelopmentRecruiting
-
Universitaire Ziekenhuizen KU LeuvenTerminated
-
Hospices Civils de LyonCompleted
-
Hythem NawaytouUniversity of MinnesotaRecruiting
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityCompleted
-
Intuitive SurgicalCompleted
-
PainQx, IncNational Institute on Drug Abuse (NIDA)CompletedChronic PainUnited States
-
Boston Scientific CorporationCompletedMitral Valve InsufficiencyBrazil, Paraguay